Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Neurobiology of Disease
|
September 16, 2006
Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism
T Darreh-Shori, S Brimijoin, A Kadir, et al.
International Archives of Occupational and Environmental Health
|
January 1, 1996
A follow-up study of five cases of aluminosis
B Sjögren, K G Ljunggren, O Almkvist, et al.
Neuroscience Letters
|
February 5, 2003
Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients
E Stefanova, K Blennow, O Almkvist, et al.
European Journal of Neurology
|
April 6, 2004
Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients
O Almkvist, T Darreh-Shori, E Stefanova, et al.
Lancet (London, England)
|
October 22, 1994
Aluminosis and dementia
B Sjögren, K G Ljunggren, O Almkvist, et al.
Journal of Neural Transmission. Supplementum
|
November 29, 2002
Conversion from preclinical to dinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation
O Almkvist, K Axelman, H Basun, et al.
Neuropsychology
|
July 1, 1997
Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study
B J Small, A Herlitz, L Fratiglioni, et al.
Archives of Neurology
|
August 1, 1990
Carbamazepine-10,11-epoxide in epilepsy. A pilot study
T Tomson, O Almkvist, B Y Nilsson, et al.
Archives of Neurology
|
June 1, 1992
White-matter hyperintensity and neuropsychological functions in dementia and healthy aging
O Almkvist, L O Wahlund, G Andersson-Lundman, et al.
Neuroscience Letters
|
October 21, 1998
Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease
V Jelic, T Dierks, K Amberla, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Neurobiology of Disease
|
September 16, 2006
Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism
T Darreh-Shori, S Brimijoin, A Kadir, et al.
International Archives of Occupational and Environmental Health
|
January 1, 1996
A follow-up study of five cases of aluminosis
B Sjögren, K G Ljunggren, O Almkvist, et al.
Neuroscience Letters
|
February 5, 2003
Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients
E Stefanova, K Blennow, O Almkvist, et al.
European Journal of Neurology
|
April 6, 2004
Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients
O Almkvist, T Darreh-Shori, E Stefanova, et al.
Lancet (London, England)
|
October 22, 1994
Aluminosis and dementia
B Sjögren, K G Ljunggren, O Almkvist, et al.
Journal of Neural Transmission. Supplementum
|
November 29, 2002
Conversion from preclinical to dinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation
O Almkvist, K Axelman, H Basun, et al.
Neuropsychology
|
July 1, 1997
Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study
B J Small, A Herlitz, L Fratiglioni, et al.
Archives of Neurology
|
August 1, 1990
Carbamazepine-10,11-epoxide in epilepsy. A pilot study
T Tomson, O Almkvist, B Y Nilsson, et al.
Archives of Neurology
|
June 1, 1992
White-matter hyperintensity and neuropsychological functions in dementia and healthy aging
O Almkvist, L O Wahlund, G Andersson-Lundman, et al.
Neuroscience Letters
|
October 21, 1998
Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease
V Jelic, T Dierks, K Amberla, et al.
Page
of 9